Sheffield Teaching Hospitals NHS Foundation Trust has launched a trial utilising smart technologies with the aim of reversing the risk of nerve damage in people living with Type 2 diabetes.
The OCEANIC trial will use technologies (including wearable sensors, smart weighing scales and activity trackers) to monitor and share patient progress on metrics, including body fat and muscle mass, with the view to reinforcing lifestyle changes.
The study group will receive personalised education and exercise programmes, delivered through virtual sessions, group sessions and one-to-one consultations, in order to explore whether “intensive strategies” to manage risk factors can halt or reverse diabetes-related nerve damage, when identified at an early stage.
Looking to the future, Professor Solomon Tesfaye, consultant physician and diabetologist at Sheffield Teaching Hospitals, comments that delivery of the trial is an “important next step in our bid to demonstrate the widespread benefit of giving patients kidney, eye and foot checks at the same time, to prevent dialysis, sight and limb loss, respectively.”
To find out more, CLICK HERE.
